Cirugia Cardiovascular最新文献

筛选
英文 中文
Controversias en cirugía cardiaca: evolución, cambio o avance en tiempos de incertidumbre 心脏手术的争议:不确定时期的演变、变化或进展
IF 0.2
Cirugia Cardiovascular Pub Date : 2026-11-01 Epub Date: 2026-01-15 DOI: 10.1016/j.circv.2025.12.004
Elio Martín Gutiérrez
{"title":"Controversias en cirugía cardiaca: evolución, cambio o avance en tiempos de incertidumbre","authors":"Elio Martín Gutiérrez","doi":"10.1016/j.circv.2025.12.004","DOIUrl":"10.1016/j.circv.2025.12.004","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"33 6","pages":"Pages 287-288"},"PeriodicalIF":0.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149399079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Credits 学分
IF 0.2
Cirugia Cardiovascular Pub Date : 2026-11-01 Epub Date: 2026-11-13 DOI: 10.1016/S1134-0096(26)00117-8
{"title":"Credits","authors":"","doi":"10.1016/S1134-0096(26)00117-8","DOIUrl":"10.1016/S1134-0096(26)00117-8","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"33 6","pages":"Page i"},"PeriodicalIF":0.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149399084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
El 39.° Congreso de la Sociedad Europea de Cirugía Cardio-Torácica y la Coincidentia Oppositorum de Giordano Bruno 39。第六届欧洲心胸外科学会大会和Giordano Bruno的反对意见
IF 0.2
Cirugia Cardiovascular Pub Date : 2026-11-01 Epub Date: 2026-02-03 DOI: 10.1016/j.circv.2026.01.001
Stefano Urso, Victor Dayan
{"title":"El 39.° Congreso de la Sociedad Europea de Cirugía Cardio-Torácica y la Coincidentia Oppositorum de Giordano Bruno","authors":"Stefano Urso, Victor Dayan","doi":"10.1016/j.circv.2026.01.001","DOIUrl":"10.1016/j.circv.2026.01.001","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"33 6","pages":"Pages 289-291"},"PeriodicalIF":0.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149399080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validez externa del metaanálisis sobre TAVI frente a cirugía en los pacientes menores de 75 años 75岁以下患者TAVI荟萃分析与手术的外部有效性
IF 0.2
Cirugia Cardiovascular Pub Date : 2026-11-01 Epub Date: 2026-05-23 DOI: 10.1016/j.circv.2026.04.003
Juan García-Lara, Alejandro Riquelme Pérez, Eduardo Pinar Bermúdez
{"title":"Validez externa del metaanálisis sobre TAVI frente a cirugía en los pacientes menores de 75 años","authors":"Juan García-Lara, Alejandro Riquelme Pérez, Eduardo Pinar Bermúdez","doi":"10.1016/j.circv.2026.04.003","DOIUrl":"10.1016/j.circv.2026.04.003","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"33 6","pages":"Pages 323-324"},"PeriodicalIF":0.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149399086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Situación actual de la revascularización de la enfermedad de tronco coronario izquierdo 左冠状动脉干病再循环的现状
IF 0.2
Cirugia Cardiovascular Pub Date : 2026-11-01 Epub Date: 2025-11-29 DOI: 10.1016/j.circv.2025.11.003
Stefano Urso, Victor Dayan, Rafael Sadaba
{"title":"Situación actual de la revascularización de la enfermedad de tronco coronario izquierdo","authors":"Stefano Urso,&nbsp;Victor Dayan,&nbsp;Rafael Sadaba","doi":"10.1016/j.circv.2025.11.003","DOIUrl":"10.1016/j.circv.2025.11.003","url":null,"abstract":"<div><div>The latest review of the chapter on the management of the left main stem disease in the guidelines for myocardial revascularization, published by the European societies of cardiothoracic surgery and cardiology in 2022, downgrades the indication for percutaneous intervention from class I to class IIa in patients with left main stem disease and a low SYNTAX score. The superiority of coronary surgery over percutaneous intervention is solidly based on the evidence from randomized clinical trials and validated by international registries. These show that surgical myocardial revascularization, compared to percutaneous intervention, provides better outcomes, especially in terms of reducing the risk of mid-terms spontaneous myocardial infarction and repeat revascularization in patients with left main stem disease. This fact reinstates coronary surgery as a fundamental and indispensable procedure in the field of myocardial revascularization. Ignoring the current scientific evidence by local Heart teams, therefore, exposes patients with left main stem disease to an unacceptable risk of adverse cardiovascular events.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"33 6","pages":"Pages 303-309"},"PeriodicalIF":0.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149399082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insuficiencia mitral funcional: resultados del intervencionismo percutáneo vs. tratamiento quirúrgico 二尖瓣功能不全:经皮干预与手术治疗的结果
IF 0.2
Cirugia Cardiovascular Pub Date : 2026-11-01 Epub Date: 2025-10-11 DOI: 10.1016/j.circv.2025.09.004
José Joaquín Cuenca Castillo
{"title":"Insuficiencia mitral funcional: resultados del intervencionismo percutáneo vs. tratamiento quirúrgico","authors":"José Joaquín Cuenca Castillo","doi":"10.1016/j.circv.2025.09.004","DOIUrl":"10.1016/j.circv.2025.09.004","url":null,"abstract":"<div><div>The approach to the management of mitral valve disease and heart failure has dramatically changed over the last decades. It is well recognized that severe mitral regurgitation secondary to ischemic or non-ischemic cardiomyopathy is associated with an excess risk of mortality. Understanding the impact of the surgical treatment modality on mortality outcomes has been difficult due to the broad spectrum of secondary mitral regurgitation (SMR) phenotypes. Over the last 30 years, surgeons have failed to provide compelling evidence to convince the medical community of the need to treat SMR in patients with severe HF. Recent evidence from randomized trials in a non-surgical eligible patients treated with transcatheter therapies, has provided a new perspective on SMR treatment. Recently published European and American guidelines confirm the key role of percutaneous treatment of SMR and in parallel, these guidelines reinforce the role of mitral valve surgery in patients who require surgical revascularization. Complex mitral valve repair combining subvalvular apparatus repair along with annuloplasty seems to be a promising approach in selected patients. Meanwhile, mitral valve replacement has become the preferred surgical strategy in most patients with advanced heart failure and severe LV remodeling or high risk of recurrent mitral regurgitation. We analyzed the results of the latest randomized trials of TEER versus medical treatment, RESHAPE-HF2, and versus mitral surgery, MATTERHORN.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"33 6","pages":"Pages 310-313"},"PeriodicalIF":0.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149399083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respuesta a Confundiendo gigantes con molinos 对混淆巨人和磨坊的回应
IF 0.2
Cirugia Cardiovascular Pub Date : 2026-11-01 Epub Date: 2026-09-03 DOI: 10.1016/j.circv.2026.06.002
Elio Martín Gutiérrez
{"title":"Respuesta a Confundiendo gigantes con molinos","authors":"Elio Martín Gutiérrez","doi":"10.1016/j.circv.2026.06.002","DOIUrl":"10.1016/j.circv.2026.06.002","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"33 6","pages":"Pages 325-327"},"PeriodicalIF":0.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149399085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tratamiento de la insuficiencia tricuspídea aislada: actualización de opciones terapéuticas y resultados quirúrgicos 三联功能不全的治疗:更新治疗方案和手术结果
IF 0.2
Cirugia Cardiovascular Pub Date : 2026-11-01 Epub Date: 2026-03-02 DOI: 10.1016/j.circv.2026.01.008
Elio Martín Gutiérrez, José Manuel Martínez-Comendador, Stefano Urso
{"title":"Tratamiento de la insuficiencia tricuspídea aislada: actualización de opciones terapéuticas y resultados quirúrgicos","authors":"Elio Martín Gutiérrez,&nbsp;José Manuel Martínez-Comendador,&nbsp;Stefano Urso","doi":"10.1016/j.circv.2026.01.008","DOIUrl":"10.1016/j.circv.2026.01.008","url":null,"abstract":"<div><div>The expansion of structural heart interventions has sparked renewed interest in this traditionally underestimated valvular disease, now recognized as carrying a poor prognosis when managed solely with medical therapy. Accordingly, this work analyzes the available evidence on invasive treatment of tricuspid regurgitation, integrating a systematic review of isolated surgery and a non-systematic review of current interventional options. A total of 54 studies spanning 45<!--> <!-->years were identified, showing historically high surgical mortality rates (8-12% in meta-analyses) attributed to delayed indication, but with a progressive decline to around 5% over the past decade thanks to earlier intervention and technical improvements. This has contributed to the 2025 ESC/EACTS guidelines upgrading transcatheter intervention to Class<!--> <!-->IIa, despite the fact that current indications—based on randomized trials comparing interventions with medical therapy—still fail to clearly define clinical scenarios or optimal patient selection. The development of dedicated devices has facilitated earlier treatment, particularly in the context of left-sided valvular disease, intracardiac shunts, or isolated forms with progression factors such as atrial fibrillation, established right ventricular dilation, or non-reversible pulmonary hypertension. Conversely, evidence from non-randomized registries supports the role of surgery in improving patient outcomes, even compared with structural interventions, especially in low-risk individuals. Overall, the analysis highlights the need for more precise criteria, holistic evaluation through a Heart Team approach, and stronger comparative evidence to define the true role of surgery and transcatheter therapy in tricuspid regurgitation.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"33 6","pages":"Pages 314-322"},"PeriodicalIF":0.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149399078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metaanálisis de TAVI frente a sustitución valvular aórtica en pacientes de edad menor a 75 años TAVI与75岁以下患者主动脉瓣膜置换的荟萃分析
IF 0.2
Cirugia Cardiovascular Pub Date : 2026-11-01 Epub Date: 2026-03-02 DOI: 10.1016/j.circv.2026.01.007
Elio Martín Gutiérrez, Joaquín Pérez Andreu, Ramón Aranda Domene, Laura Alfonso Colomer, María José Alcaraz García, Sergio Juan Cánovas López
{"title":"Metaanálisis de TAVI frente a sustitución valvular aórtica en pacientes de edad menor a 75 años","authors":"Elio Martín Gutiérrez,&nbsp;Joaquín Pérez Andreu,&nbsp;Ramón Aranda Domene,&nbsp;Laura Alfonso Colomer,&nbsp;María José Alcaraz García,&nbsp;Sergio Juan Cánovas López","doi":"10.1016/j.circv.2026.01.007","DOIUrl":"10.1016/j.circv.2026.01.007","url":null,"abstract":"<div><div>The 2025 update of the ESC-EACTS guidelines for the management of valvular heart disease has lowered the age threshold for considering transcatheter aortic valve implantation (TAVI) from 75 to 70<!--> <!-->years in patients with tricuspid aortic valves and suitable anatomy. This change raises questions about whether sufficient evidence supports its applicability in younger, low-surgical-risk patients compared with surgical aortic valve replacement (SAVR). We conducted a meta-analysis comparing TAVI versus SAVR in patients aged ≤<!--> <!-->75<!--> <!-->years to assess whether current evidence justifies this modification in clinical recommendations. A systematic search was performed in PubMed including all studies comparing postprocedural mortality and morbidity between TAVI and SAVR in patients with severe aortic stenosis and a mean age ≤<!--> <!-->75<!--> <!-->years. After quality assessment using the Newcastle-Ottawa scale, 11 studies were selected (4 randomized clinical trials, 6 observational studies, and 1 post-hoc analysis). Meta-analyses were conducted using fixed- or random-effects models according to heterogeneity (I<sup>2</sup>), and effect sizes were expressed as relative risk (RR) using the Mantel-Haenszel method. A total of 29,673 patients were analyzed (8,964 TAVI vs. 20,709 SAVR). The pooled quantitative analysis showed a significant survival benefit of SAVR over TAVI during follow-up (RR<!--> <!-->=<!--> <!-->1.55; 95%<!--> <!-->CI: 1.09-2.21). Subgroup analyses revealed no significant difference between treatment options in randomized trials (RR<!--> <!-->=<!--> <!-->0.90; 95%<!--> <!-->CI: 0.57-1.44), whereas propensity-matched observational studies demonstrated lower mortality with SAVR (RR<!--> <!-->=<!--> <!-->2.30; 95%<!--> <!-->CI: 1.67-3.16). Surgery was associated with a lower need for permanent pacemaker implantation (RR<!--> <!-->=<!--> <!-->1.40; <em>P</em> <!-->=<!--> <!-->.03) and fewer reinterventions (RR<!--> <!-->=<!--> <!-->1.34; <em>P</em> <!-->&lt;<!--> <!-->.00001), with no differences in stroke, readmission, or endocarditis rates. In patients ≤<!--> <!-->75<!--> <!-->years with severe aortic stenosis, SAVR remains associated with better survival and lower morbidity related to pacemaker implantation and reintervention. Current evidence does not support lowering the recommended age for TAVI to 70<!--> <!-->years in low-risk patients, underscoring the need for extended follow-up and new long-term randomized trials in younger populations.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"33 6","pages":"Pages 292-302"},"PeriodicalIF":0.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149399081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fístula coronaria gigante en un paciente pediátrico 儿科患者的巨冠状动脉瘘
IF 0.2
Cirugia Cardiovascular Pub Date : 2026-09-01 Epub Date: 2025-05-10 DOI: 10.1016/j.circv.2025.04.001
David Ramírez-Cedillo, Jaime Lopez-Taylor, Carlos Jiménez Fernandez, Miguel A. Medina Andrade, Italo Masini Aguilera, Halina Olmos Sanchez, Paris Daniel Ramirez Barajas, Cinthia Ramirez Frias, Rocio A. Peña-Juárez
{"title":"Fístula coronaria gigante en un paciente pediátrico","authors":"David Ramírez-Cedillo,&nbsp;Jaime Lopez-Taylor,&nbsp;Carlos Jiménez Fernandez,&nbsp;Miguel A. Medina Andrade,&nbsp;Italo Masini Aguilera,&nbsp;Halina Olmos Sanchez,&nbsp;Paris Daniel Ramirez Barajas,&nbsp;Cinthia Ramirez Frias,&nbsp;Rocio A. Peña-Juárez","doi":"10.1016/j.circv.2025.04.001","DOIUrl":"10.1016/j.circv.2025.04.001","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"33 5","pages":"Pages 282-285"},"PeriodicalIF":0.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148861847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书